电子邮件 | mpo***@***.com | 获取Email |
---|
电子邮件 | mpo***@***.com | 获取Email |
---|
NasVax develops improved vaccines and immunotherapeutic products. The company has four distinct product areas: i. oral anti-CD3 monoclonal antibody immunotherapeutic; ii. VaxiSome® technology, which is an adjuvant-delivery system for enhancing the immunogenicity of vaccines and immunotherapeutics; iii. group-common pneumococcal vaccine, which is a protein-based vaccine that could become the field's third-generation product; and iv. BBS1-based immunotherapeutics for Alzheimer's disease.
公司 | Nasvax |
---|---|
职位 | Researcher |
地点 | Israel |
http://www.linkedin.com/in/maxim-portnoi-6b3b4332 | |
部门 | |
头衔 | Researcher at Nasvax |
Maxim Portnoi 在 Nasvax 担任 Researcher at Nasvax
Maxim Portnoi 在 Nasvax 的职位是 Researcher at Nasvax
Maxim Portnoi 的电子邮件地址是 mpo***@***.com
Maxim Portnoi 的电话号码是 -
Maxim Portnoi 的公司电话号码是 -
Maxim Portnoi 在 research 工作。
Maxim Portnoi 的一些同事包括Michael Tal、Irit Inbar、Maxim Portnoi、Dorit KreinerErez C、。
Maxim Portnoi联系方式: 电子邮件地址:mpo***@***.com 电话号码:-
Maxim Portnoi 的个人领英是:http://www.linkedin.com/in/maxim-portnoi-6b3b4332
Maxim Portnoi 的办公地点:18 Einstien St. Kiryat Weizmann, Science Park, P.O.B 4122, Ness Zionna, IL
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd